203 related articles for article (PubMed ID: 32037441)
1. Identification and activity of the functional complex between hnRNPL and the pseudoexfoliation syndrome-associated lncRNA, LOXL1-AS1.
Schmitt HM; Johnson WM; Aboobakar IF; Strickland S; Gomez-Caraballo M; Parker M; Finnegan L; Corcoran DL; Skiba NP; Allingham RR; Hauser MA; Stamer WD
Hum Mol Genet; 2020 Jul; 29(12):1986-1995. PubMed ID: 32037441
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations.
Schlötzer-Schrehardt U
Exp Eye Res; 2009 Apr; 88(4):776-85. PubMed ID: 18809397
[TBL] [Abstract][Full Text] [Related]
3. Lysyl oxidase-like 1-antisense 1 (LOXL1-AS1) lncRNA differentially regulates gene and protein expression, signaling and morphology of human ocular cells.
Schmitt HM; Hake KM; Perkumas KM; Lê BM; Suarez MF; De Ieso ML; Rahman RS; Johnson WM; Gomez-Caraballo M; Ashley-Koch AE; Hauser MA; Stamer WD
Hum Mol Genet; 2023 Oct; 32(21):3053-3062. PubMed ID: 37540217
[TBL] [Abstract][Full Text] [Related]
4. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients.
Schlötzer-Schrehardt U; Pasutto F; Sommer P; Hornstra I; Kruse FE; Naumann GO; Reis A; Zenkel M
Am J Pathol; 2008 Dec; 173(6):1724-35. PubMed ID: 18974306
[TBL] [Abstract][Full Text] [Related]
5. LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma.
Schlötzer-Schrehardt U; Hammer CM; Krysta AW; Hofmann-Rummelt C; Pasutto F; Sasaki T; Kruse FE; Zenkel M
Ophthalmology; 2012 Sep; 119(9):1832-43. PubMed ID: 22633114
[TBL] [Abstract][Full Text] [Related]
6. Association of LOXL1 polymorphisms with pseudoexfoliation, glaucoma, intraocular pressure, and systemic diseases in a Greek population. The Thessaloniki eye study.
Anastasopoulos E; Coleman AL; Wilson MR; Sinsheimer JS; Yu F; Katafigiotis S; Founti P; Salonikiou A; Pappas T; Koskosas A; Katopodi T; Lambropoulos A; Topouzis F
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4238-43. PubMed ID: 24917141
[TBL] [Abstract][Full Text] [Related]
7. The protective variant rs7173049 at LOXL1 locus impacts on retinoic acid signaling pathway in pseudoexfoliation syndrome.
Berner D; Hoja U; Zenkel M; Ross JJ; Uebe S; Paoli D; Frezzotti P; Rautenbach RM; Ziskind A; Williams SE; Carmichael TR; Ramsay M; Topouzis F; Chatzikyriakidou A; Lambropoulos A; Sundaresan P; Ayub H; Akhtar F; Qamar R; Zenteno JC; Cruz-Aguilar M; Astakhov YS; Dubina M; Wiggs J; Ozaki M; Kruse FE; Aung T; Reis A; Khor CC; Pasutto F; Schlötzer-Schrehardt U
Hum Mol Genet; 2019 Aug; 28(15):2531-2548. PubMed ID: 30986821
[TBL] [Abstract][Full Text] [Related]
8. Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
Pasutto F; Krumbiegel M; Mardin CY; Paoli D; Lämmer R; Weber BH; Kruse FE; Schlötzer-Schrehardt U; Reis A
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1459-63. PubMed ID: 18385063
[TBL] [Abstract][Full Text] [Related]
9. Pseudoexfoliation syndrome and glaucoma: from genes to disease mechanisms.
Schlötzer-Schrehardt U; Khor CC
Curr Opin Ophthalmol; 2021 Mar; 32(2):118-128. PubMed ID: 33332884
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants and cellular stressors associated with exfoliation syndrome modulate promoter activity of a lncRNA within the LOXL1 locus.
Hauser MA; Aboobakar IF; Liu Y; Miura S; Whigham BT; Challa P; Wheeler J; Williams A; Santiago-Turla C; Qin X; Rautenbach RM; Ziskind A; Ramsay M; Uebe S; Song L; Safi A; Vithana EN; Mizoguchi T; Nakano S; Kubota T; Hayashi K; Manabe S; Kazama S; Mori Y; Miyata K; Yoshimura N; Reis A; Crawford GE; Pasutto F; Carmichael TR; Williams SE; Ozaki M; Aung T; Khor CC; Stamer WD; Ashley-Koch AE; Allingham RR
Hum Mol Genet; 2015 Nov; 24(22):6552-63. PubMed ID: 26307087
[TBL] [Abstract][Full Text] [Related]
11. Lysyl oxidase-like 1 gene in the reversal of promoter risk allele in pseudoexfoliation syndrome.
Dubey SK; Hejtmancik JF; Krishnadas SR; Sharmila R; Haripriya A; Sundaresan P
JAMA Ophthalmol; 2014 Aug; 132(8):949-55. PubMed ID: 24809751
[TBL] [Abstract][Full Text] [Related]
12. Association of Lysyl Oxidase-Like 1 Gene Polymorphism in Turkish Patients With Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma.
Asfuroglu M; Cavdarli B; Koz OG; A Yarangumeli A; Ozdemir EY
J Glaucoma; 2017 Feb; 26(2):e54-e57. PubMed ID: 27753755
[TBL] [Abstract][Full Text] [Related]
13. Biological effect of LOXL1 coding variants associated with pseudoexfoliation syndrome.
Sharma S; Martin S; Sykes MJ; Dave A; Hewitt AW; Burdon KP; Ronci M; Voelcker NH; Craig JE
Exp Eye Res; 2016 May; 146():212-223. PubMed ID: 26997634
[TBL] [Abstract][Full Text] [Related]
14. Association of polymorphisms in APOE and LOXL1 with pseudoexfoliation syndrome and pseudoexfoliation glaucoma in a Turkish population.
Yaylacioğlu Tuncay F; Aktaş Z; Ergün MA; Ergün SG; Hasanreisoğlu M; Hasanreisoğlu B
Ophthalmic Genet; 2017; 38(1):95-97. PubMed ID: 27028259
[No Abstract] [Full Text] [Related]
15. LOXL1 promoter haplotypes are associated with exfoliation syndrome in a U.S. Caucasian population.
Fan BJ; Pasquale LR; Rhee D; Li T; Haines JL; Wiggs JL
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2372-8. PubMed ID: 21212179
[TBL] [Abstract][Full Text] [Related]
16. Association of IL-10 gene promoter polymorphisms with susceptibility to pseudoexfoliation syndrome, pseudoexfoliative and primary open-angle glaucoma.
Fakhraie G; Parvini F; Ghanavi J; Saif S; Farnia P
BMC Med Genet; 2020 Feb; 21(1):32. PubMed ID: 32050932
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between lysyl oxidase-like 1 polymorphism in pseudoexfoliation syndrome and pseudoexfoliation glaucoma in North Indian population.
Pandav SS; Chakma P; Khera A; Chugh N; Gupta PC; Thattaruthody F; Seth NG; Raj S; Kaushik S; Khullar M; Ram J
Eur J Ophthalmol; 2019 Jul; 29(4):431-436. PubMed ID: 30189755
[TBL] [Abstract][Full Text] [Related]
18. Update on pseudoexfoliation syndrome pathogenesis and associations with intraocular pressure, glaucoma and systemic diseases.
Anastasopoulos E; Founti P; Topouzis F
Curr Opin Ophthalmol; 2015 Mar; 26(2):82-9. PubMed ID: 25594764
[TBL] [Abstract][Full Text] [Related]
19. Exfoliation syndrome and exfoliation glaucoma-associated LOXL1 variations are not involved in pigment dispersion syndrome and pigmentary glaucoma.
Rao KN; Ritch R; Dorairaj SK; Kaur I; Liebmann JM; Thomas R; Chakrabarti S
Mol Vis; 2008 Jul; 14():1254-62. PubMed ID: 18618003
[TBL] [Abstract][Full Text] [Related]
20. [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].
Schlötzer-Schrehardt U
Ophthalmologe; 2012 Oct; 109(10):944-51. PubMed ID: 23053330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
